Millions of vaccines to be made in Oxfordshire, and government unveils £50 million fund, in double boost for life sciences

The MHRA is consulting with UK stakeholders to gather feedback and comments on a new international guideline for the appropriate inclusion and/or retention of pregnant and/or breast-feeding individuals in clinical trials of medicines.

The updated safety measures will strengthen the MHRA’s ability to monitor safe prescribing while supporting patient access to treatment across all age groups.

Information about the reproductive risks of taking valproate medicines and the measures in place to reduce potential harm.

Information on Medicines and Healthcare products Regulatory Agency spending over £25,000.

Eaststone Limited is initiating a recall of all batches of quetiapine oral suspension products due to a potential risk of overdose, which could have consequences for the safety of patients.

List of Field Safety Notices for 22-26 December 2025